Vantage Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 660 |
|
|
2018
Q2 | $5K | Hold |
200
| – | – | ﹤0.01% | 639 |
|
|
2018
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 711 |
|
|
2017
Q4 | $4K | Hold |
200
| – | – | ﹤0.01% | 705 |
|
|
2017
Q3 | $4K | Sell |
200
-340
| -63% | -$6.8K | ﹤0.01% | 688 |
|
|
2017
Q2 | $18K | Sell |
540
-125
| -19% | -$4.17K | 0.01% | 444 |
|
|
2017
Q1 | $21K | Hold |
665
| – | – | 0.01% | 397 |
|
|
2016
Q4 | $24K | Hold |
665
| – | – | 0.01% | 371 |
|
|
2016
Q3 | $31K | Sell |
665
-28
| -4% | -$1.31K | 0.01% | 316 |
|
|
2016
Q2 | $35K | Buy |
693
+78
| +13% | +$3.94K | 0.01% | 313 |
|
|
2016
Q1 | $33K | Buy |
615
+75
| +14% | +$4.02K | 0.01% | 308 |
|
|
2015
Q4 | $35K | Buy |
540
+340
| +170% | +$22K | 0.02% | 288 |
|
|
2015
Q3 | $11K | Hold |
200
| – | – | 0.01% | 481 |
|
|
2015
Q2 | $12K | Sell |
200
-200
| -50% | -$12K | 0.01% | 449 |
|
|
2015
Q1 | $25K | Buy |
400
+200
| +100% | +$12.5K | 0.01% | 451 |
|
|
2014
Q4 | $12K | Hold |
200
| – | – | 0.01% | 470 |
|
|
2014
Q3 | $11K | Hold |
200
| – | – | 0.01% | 469 |
|
|
2014
Q2 | $10K | Hold |
200
| – | – | 0.01% | 473 |
|
|
2014
Q1 | $11K | Hold |
200
| – | – | 0.01% | 422 |
|
|
2013
Q4 | $8K | Buy |
+200
| New | +$8K | 0.01% | 433 |
|